1.0
6 June 2023
Former employee, more than 3 years
Utrecht
Recommend
CEO approval
Business outlook
Pros
Frequent parties and regular gifts for employees
Cons
Despite the CEO telling the same lines at every event, gathering and conference about Genmab being a leading biotech, an innovative powerhouse in reality there's very little, relevant, knowledge in the company, bad management and it's more about politics then about improving the lives of cancer patients. The integrity with which the company is run is questionable.